Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn–AhR–AQP4 signaling pathway

por Du, Lisha, Xing, Zikang, Tao, Bangbao, Li, Tianqi, Yang, Dan, Li, Weirui, Zheng, Yuanting, Kuang, Chunxiang, Yang, Qing
Publicado 2020

Correction: Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn–AhR–AQP4 signaling pathway

por Du, Lisha, Xing, Zikang, Tao, Bangbao, Li, Tianqi, Yang, Dan, Li, Weirui, Zheng, Yuanting, Kuang, Chunxiang, Yang, Qing
Publicado 2021

Amyloid β neurotoxicity is IDO1–Kyn–AhR dependent and blocked by IDO1 inhibitor

por Duan, Zhenzhen, Zhang, Shengnan, Liang, Heng, Xing, Zikang, Guo, Leilei, Shi, Lei, Du, Lisha, Kuang, Chunxiang, Takikawa, Osamu, Yang, Qing
Publicado 2020

H(2)S suppresses indoleamine 2, 3-dioxygenase 1 and exhibits immunotherapeutic efficacy in murine hepatocellular carcinoma

por Yang, Dan, Li, Tianqi, Li, Yinlong, Zhang, Shengnan, Li, Weirui, Liang, Heng, Xing, Zikang, Du, Lisha, He, Jinchao, Kuang, Chunxiang, Yang, Qing
Publicado 2019

Knowledge atlas of antibody-drug conjugates on CiteSpace and clinical trial visualization analysis

por Yao, Peizhuo, Zhang, Yinbin, Zhang, Shuqun, Wei, Xinyu, Liu, Yanbin, Du, Chong, Hu, Mingyou, Feng, Cong, Li, Jia, Zhao, Fang, Li, Chaofan, Li, Zhen, Du, Lisha
Publicado 2023